Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Friedenson

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Medgenmed : Medscape General Medicine|December 22, 2005
BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarianBernard Friedenson
Medgenmed : Medscape General Medicine|June 23, 2004
Assessing and managing breast cancer risk: clinical tools for advising patientsBernard Friedenson
Jmirx Med|January 30, 2025
Identifying Safeguards Disabled by Epstein-Barr Virus Infections in Genomes From Patients With Breast Cancer: Chromosomal Bioinformatics AnalysisBernard Friedenson
BMC Cancer|August 9, 2007
The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancersBernard Friedenson
Biomedical Informatics Insights|August 9, 2019
A Genome Model to Explain Major Features of Neurodevelopmental Disorders in NewbornsBernard Friedenson
Medical Hypotheses|August 16, 2011
A common environmental carcinogen unduly affects carriers of cancer mutations: carriers of genetic mutations in a specific protective response are more susceptible to an environmental carcinogenBernard Friedenson
Functional & Integrative Genomics|September 24, 2013
Mutations in components of antiviral or microbial defense as a basis for breast cancerBernard Friedenson
Molecular Medicine (Cambridge, Mass.)|September 14, 2012
Evidence that BRCA1- or BRCA2-associated cancers are not inevitableBess Levin, Denise Lech, Bernard Friedenson
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Medgenmed : Medscape General Medicine|December 22, 2005
BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarianBernard Friedenson
Medgenmed : Medscape General Medicine|June 23, 2004
Assessing and managing breast cancer risk: clinical tools for advising patientsBernard Friedenson
Jmirx Med|January 30, 2025
Identifying Safeguards Disabled by Epstein-Barr Virus Infections in Genomes From Patients With Breast Cancer: Chromosomal Bioinformatics AnalysisBernard Friedenson
BMC Cancer|August 9, 2007
The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancersBernard Friedenson
Biomedical Informatics Insights|August 9, 2019
A Genome Model to Explain Major Features of Neurodevelopmental Disorders in NewbornsBernard Friedenson
Medical Hypotheses|August 16, 2011
A common environmental carcinogen unduly affects carriers of cancer mutations: carriers of genetic mutations in a specific protective response are more susceptible to an environmental carcinogenBernard Friedenson
Functional & Integrative Genomics|September 24, 2013
Mutations in components of antiviral or microbial defense as a basis for breast cancerBernard Friedenson
Molecular Medicine (Cambridge, Mass.)|September 14, 2012
Evidence that BRCA1- or BRCA2-associated cancers are not inevitableBess Levin, Denise Lech, Bernard Friedenson
Pageof 1